Strategy and policy consultant in artificial intelligence and emerging technology. Twenty years of experience in healthcare, technology, and financial services as an investment banker, entrepreneur, and operating partner.
Dennis Chornenky is a senior advisor and strategy consultant in artificial intelligence and emerging technology. With twenty years of experience in healthcare, technology, and financial services, he advises Fortune 500 companies, policy makers, and startups. Throughout his business career Dennis has managed senior leadership teams, M&A deal teams, and product development and sales teams. His experience includes investment banking at Lazard, building an alternative investments and trading business at Morgan Stanley, and founding an AI-driven telemedicine startup in Silicon Valley and a drone startup at MIT.
In a research capacity, Dennis has applied machine learning methodologies to gain insight into the expanding adoption of emerging technologies. At the Health Care Policy Department at Harvard Medical School, he analyzed hundreds of millions of insurance claims to better understand social determinants of health and consumer adoption of telemedicine and digital health tools. In collaboration with Deloitte Digital and the MIT Analytics Lab, Dennis developed methods for auditing algorithms for bias and educating decision makers about the risks and trade-offs of deploying artificial intelligence. His pioneering work on AI ethics has covered public and private sector applications, including criminal sentencing, medical decision making, digital marketing, and employment screening. To promote socially responsible use of AI, Dennis has advised organizations on adopting Algorithm Auditing Committees and AI Policy Statements.
In his personal time, Dennis spends time with his family and supports nonprofit and community organizations that promote civic engagement and better access to education and healthcare. Dennis holds a Bachelor of Arts in Political Science from UC Berkeley, a Master of Business Administration from the University of Oxford, Saïd Business School, and a Master of Public Health from the Harvard T.H. Chan School of Public Health, where he was trained as an epidemiologist and clinical data scientist. He also holds a Master of Science in Management of Technology and a Certificate in Business Analytics from the MIT Sloan School of Management, where he was a Sloan Fellow in Global Leadership and Innovation.